Povidone iodine plus neosporin in superficial burns--a continuing study

Burns. 1997 Nov-Dec;23(7-8):626-8. doi: 10.1016/s0305-4179(97)00069-7.

Abstract

A total of 1053 patients with superficial burn injury were treated with povidone iodine plus neosporin (PVP + N) and the results after treatment were compared with those obtained after treating 1089 patients with silver sulphadiazine (SSD). Qualitative analysis showed Staphylococcus aureus and Pseudomonas spp. to be the most common infecting organisms. Quantitatively, fewer patients showed infection on the 7th and 18th day post-treatment in the PVP + N group (P < 0.01 and P < 0.001, respectively). Similarly, healing times were also better with PVP + N, with a maximum number of patients having healed within 15 days (P < 0.001). However, the mortality rates were not much different between the two groups.

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial

MeSH terms

  • Administration, Topical
  • Anti-Infective Agents, Local / administration & dosage*
  • Anti-Infective Agents, Local / economics
  • Bacitracin / administration & dosage
  • Bacitracin / economics
  • Bacterial Infections / prevention & control*
  • Burns / drug therapy*
  • Burns / mortality
  • Burns / physiopathology
  • Costs and Cost Analysis
  • Drug Combinations
  • Drug Therapy, Combination / administration & dosage*
  • Female
  • Humans
  • India
  • Injury Severity Score
  • Male
  • Neomycin / administration & dosage
  • Neomycin / economics
  • Polymyxin B / administration & dosage
  • Polymyxin B / economics
  • Povidone-Iodine / administration & dosage*
  • Povidone-Iodine / economics
  • Prospective Studies
  • Silver Sulfadiazine / administration & dosage
  • Silver Sulfadiazine / economics
  • Survival Rate
  • Treatment Outcome

Substances

  • Anti-Infective Agents, Local
  • Drug Combinations
  • Bacitracin
  • bacitracin zinc, neomycin sulfate, polymyxin B, drug combination
  • Povidone-Iodine
  • Neomycin
  • Polymyxin B
  • Silver Sulfadiazine